Skip to main content
SpringerLink
Log in

Identifikation der molekularen Grundlagen der Metastasierung zur Entwicklung neuer Therapiestrategien des metastasierten Prostatakarzinoms

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Zelefsky MJ, Fuks Z, Happersett L et al. (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55: 241

    Article  PubMed  CAS  Google Scholar 

  2. Martinez A, Gonzalez JA, Spencer W et al. (2003) Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169: 974–980

    Article  PubMed  Google Scholar 

  3. Conrad S, Graefen M, Pichlmeier U et al. (2002) Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol 167: 521–525

    Article  PubMed  Google Scholar 

  4. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9: 653–660

    Article  PubMed  CAS  Google Scholar 

  5. Neri D, Bicknell R (2005) Tumour vascular targeting. Nature Rev 5: 436–446

    Article  CAS  Google Scholar 

  6. Burrows FJ, Thorpe PE (1993) Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 90: 8996–9000

    Article  PubMed  CAS  Google Scholar 

  7. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461–465

    Article  PubMed  CAS  Google Scholar 

  8. Bonnet D, Dick JE (1997) Human acute leukaemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730–737

    Article  PubMed  CAS  Google Scholar 

  9. Singh SK, Hawkins C, Clarke ID et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396–401

    Article  PubMed  CAS  Google Scholar 

  10. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111–115

    Article  PubMed  CAS  Google Scholar 

  11. Fang D, Nguyen TK, Leishear K et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328–9337

    Article  PubMed  CAS  Google Scholar 

  12. Collins AT, Maitland NJ (2006) Prostate cancer stem cells. Eur J Cancer 42: 1213–1218

    Article  PubMed  CAS  Google Scholar 

  13. Bao S, Wu Q, McLendon RE et al. (2007) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756–760

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molekularbiologische und urologische Forschergruppe (MUF), Urologische Universitätsklinik Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    M. Schenck, C. Boergermann, F. vom Dorp, Y. Busch & H. Ruebben

  2. Klinik für Strahlentherapie, Universitätsklinikum Duisburg-Essen, Essen, Deutschland

    M. Groneberg & M. Stuschke

  3. Institut für Pathologie, Universitätsklinikum Duisburg-Essen, Essen, Deutschland

    K.W. Schmid

  4. Institut für Molekularbiologie, Universitätsklinikum Duisburg-Essen, Essen, Deutschland

    M. Schenck, Y. Busch, B. Wilker, S. Keitsch, S. Moyrer & E. Gulbins

Authors
  1. M. Schenck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Boergermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. vom Dorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Busch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Groneberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Wilker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Keitsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Moyrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K.W. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Stuschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Ruebben
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E. Gulbins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Schenck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schenck, M., Boergermann, C., vom Dorp, F. et al. Identifikation der molekularen Grundlagen der Metastasierung zur Entwicklung neuer Therapiestrategien des metastasierten Prostatakarzinoms. Urologe 46, 1261–1262 (2007). https://doi.org/10.1007/s00120-007-1387-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1387-5

Search

Navigation